In fact, a transverse myelitis case has been reported in a volunteer patient immunized against the SARS-CoV-2, where the protective agent was an adenovirus-based vaccine containing glycosylated S protein on its surface [52,53]. Here, PROS1 is linked to transverse myelitis.